financetom
Business
financetom
/
Business
/
Ennis' Fiscal Q4 Earnings, Revenue Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ennis' Fiscal Q4 Earnings, Revenue Decline
Apr 22, 2024 4:18 AM

06:50 AM EDT, 04/22/2024 (MT Newswires) -- Ennis (EBF) reported fiscal Q4 earnings Monday of $0.39 per diluted share, down from $0.47 a year earlier.

Analysts' estimates were not readily available for comparison.

Revenue for the quarter ended Feb. 29 was $97.4 million, compared with $102.7 million a year earlier.

A single analyst surveyed by Capital IQ expected $101.9 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Casella Waste Systems to Acquire Royal Carting and Welsh Sanitation
Casella Waste Systems to Acquire Royal Carting and Welsh Sanitation
Sep 9, 2024
08:23 AM EDT, 09/09/2024 (MT Newswires) -- Casella Waste Systems ( CWST ) said Monday it has agreed to acquire Royal Carting and Welsh Sanitation and related real estate assets. The transaction is expected to close in Q4. Casella said it would gain access to two solid waste collection operations and two transfer stations in New York from the acquisition....
Chinese stock exchanges add Alibaba into Stock Connect Scheme
Chinese stock exchanges add Alibaba into Stock Connect Scheme
Sep 9, 2024
BEIJING, Sept 9 (Reuters) - China's Shanghai and Shenzhen stock exchanges will include Chinese e-commerce giant Alibaba Group ( BABA ) and some other companies into its Stock Connect cross-border investment scheme from Tuesday, separate filings showed on Monday. This move will integrate Alibaba ( BABA ) into a program linking the Shenzhen and Shanghai stock exchanges with the Hong...
Rezolute Says FDA Removes Partial Clinical Holds on Potential Hypoglycemia Treatment
Rezolute Says FDA Removes Partial Clinical Holds on Potential Hypoglycemia Treatment
Sep 9, 2024
08:20 AM EDT, 09/09/2024 (MT Newswires) -- Rezolute ( RZLT ) said Monday that the US Food and Drug Administration has removed partial clinical holds on ersodetug or RZ358, the biotech firm's drug candidate to treat hypoglycemia caused by congenital hyperinsulinism. The company said it will soon begin startup activities in the US for a global phase 3 study, with...
Northvolt to cut costs, explore strategic partnerships
Northvolt to cut costs, explore strategic partnerships
Sep 9, 2024
STOCKHOLM, Sept 9 (Reuters) - Swedish battery maker Northvolt said on Monday it would cut costs and explore future strategic partnerships while focusing on its large-scale cell manufacturing as the company continues to scale back its rapid expansion. The announcement follows a major review of Northvolt's strategy intended to refocus its business following a series of setbacks such as production...
Copyright 2023-2025 - www.financetom.com All Rights Reserved